Clinical Trials Browser

INDUSTRY × ranpirnase × Clear all

NCT02535104 2018-06-06

Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV)

Phase 1/2 Completed

Condylomata Acuminata, Sexually Transmitted Diseases, Papillomavirus Infections

NCT01184287 2015-09-02

A Study Of Ranpirnase(Onconase®) To Pemetrexed Plus Carboplatin In Patients With Non-Squamous Non-Small Cell Lung Cancer

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms